Sittig MP, Luu M, Yoshida EJ, et al. - In insured patients younger than 65 with head and neck squamous cell carcinoma (HNSCC) treated with definitive radiotherapy, researchers described the impact of primary payer on overall survival (OS). For patients < 65 years of age diagnosed between 2004 and 2014 undergoing definitive radiotherapy ± chemotherapy for cancers of the nasopharynx, oropharynx, hypopharynx and larynx, the National Cancer Database was searched. Overall, 27,292 insured individuals have been identified, including 17,060 with private insurance. Findings suggested that patients < 65 with HNSCC undergoing definitive radiation with private health insurance have significantly longer survival compared with patients with government-sponsored insurance. It highlights the need, but not necessary, to expand access to care to reduce the major inequalities in the US healthcare system.